![Markus Puhlmann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 400 247 $ au 31/07/2026
Markus Puhlmann is Chief Medical Officer at Perspective Therapeutics, Inc. since 2023.
Formerly, Dr. Puhlmann was Head-Global Clinical Development at Seagen, Inc. from 2019 to 2022 and Principal at Merck & Co., Inc. from 2015 to 2019.
Education includes a doctorate from Ludwig-Maximilians-Universität München and an MBA from McDonough School of Business.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 02/04/2026 | 137 542 ( 0,12 % ) | 400 247 $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| PERSPECTIVE THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 03/02/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
| SEAGEN INC. | Corporate Officer/Principal | 01/01/2022 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2019 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cancer medicines | Health Technology |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
McDonough School of Business
 McDonough School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Perspective Therapeutics, Inc.
 Perspective Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops medical technology devices | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
